About Us


Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~40,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.

Our global portfolio includes best-in-class, iconic brand-name products as well as global key brands; generics, including branded and complex generics; biosimilars; and over-the-counter offerings across a wide range of therapeutic areas. We are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.

At Viatris, we have one of the strongest global commercial infrastructures in the industry, with a balanced reach across North America, Europe, the Asia Pacific region and emerging markets. Our high quality global manufacturing, scientific excellence and vast supply chain network mean we are uniquely positioned to improve access to medicine for patients worldwide.

We are domiciled in the United States, with three global centers in Pittsburgh, Pennsylvania, U.S.; Shanghai, China; and Hyderabad, India. We operate approximately 50 manufacturing sites, which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. And we maintain an industry-leading pipeline, composed of numerous complex generics, biosimilars and global key brands.

As we work to fully transition to the Viatris brand commercially and operationally around the world, you may continue to see both the Mylan and Upjohn names in certain markets. Throughout this process, our priority remains serving patients by finding innovative solutions to meet their evolving healthcare needs.


The Malaysian Society of Hypertension (MSH) was officially registered under the Registrar of Society in 1993. The main aim of the society is to promote public education on hypertension, to help towards optimum control of hypertension and encouraging research and publication towards better care in the management of hypertension.

Specific Objectives of the Society are to:

  • Promote basic and clinical studies and educate doctors and para-medical staffs regarding hypertension and to propagate knowledge on hypertension
  • Educate the public and to be of service to all hypertensives in Malaysia and others interested in hypertension and to advise hypertensive patients to remain active and to lead a normal and useful life.
  • Promote cost-effective management and control of hypertension.
  • Liaise with international bodies related to hypertension and to organise educational meetings or provide services at local and regional levels.
  • Compile, print, publish and distribute brochures and/or journals by experts on hypertension.


NHAM has contributed to teaching and training in cardiology. It mooted the idea of the Sukaman Lecture, nominated Dr Charles Toh as the first recipient of this Award and Dr Nik Zainal as the second speaker. The NHAM was responsible for stimulating research in cardiology. It has organized several teaching seminars in echocardiography, coronary angioplasty, heart failure, cardiac pacing and electrophysiology.

NHAM is now a success story. It owes its success to many members who were willing to serve in the Council and sacrifice their time and effort. But success is a journey not a destination. It cannot end.


The Malaysian Dietitian's Association (MDA) is a professional body for dietitians established in 1994. Since its inception, MDA serves as a platform to represent dietitians in Malaysia in order to achieve our shared vision and mission.


The National Stroke Association of Malaysia (NASAM) is South East Asia’s first non-profit organisation that offers rehabilitation services for stroke survivors and support to their families. A strong advocate of ‘There is life after stroke’, the main objectives of NASAM is:

  • To provide rehabilitation services to enable stroke survivors to return to as normal a life as possible within the limits of their disabilities
  • To promote the concept of stroke prevention by raising public awareness on the risk of stroke

It is NASAM's long term mission to make stroke rehabilitation accessible to as many stroke survivors as possible especially to the poor and those living in rural areas. Today, NASAM operates nine centres in Petaling Jaya, Ampang, Penang, Perak, Malacca, Sabah, Johor, Kuantan and Kedah, with around 500 stroke survivors attending rehabilitation sessions on a daily basis.